medigraphic.com
SPANISH

Revista Médica Sinergia

Revista Médica Sinergia
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 04

<< Back Next >>

Revista Médica Sinergia 2020; 5 (04)

Black fungi onychomycosis: onicopathy with special characteristics

Antúnez OJA, Montero BF, Pabón PCA
Full text How to cite this article

Language: Spanish
References: 27
Page: 1-12
PDF size: 186.42 Kb.


Key words:

onychomycosis, phaeohyphomycosis, tinea pedis, mycoses.

ABSTRACT

Black fungal onychomycosis also known as pheohifomycosis of the nail, is part of the condition called fungal melanonychia, which has been known for several years. The etiologic agents of this infection are black or demataceous fungi, which usually act as opportunistic pathogens causing invasion and infection, taking advantage from a predisposing factor. It has a universal distribution and is endemic in several countries. It can be found in different climates and ecosystems. This type of fungi has specific pathogenicity factors that make it easier for them to develop in the host. Affected patients may have a variable spectrum in the clinical presentation of nail pathology, which is important to know so that an appropriate differential diagnosis is made with other pathologies both benign and malignant. Currently, for the diagnosis of this type of onychomycosis, it is required to have a direct microscopic observation, cultures in unconventional media and a high clinical suspicion. With regard to antifungal therapy, it is known to be exceptionally difficult and that this kind of fungi have a poor response to the antifungals that are used nowadays.


REFERENCES

  1. Ajello L, Georg LK, Steigbigel RT, Wang CJK. A case of phaeohyphomycosis caused by a new species of Phialophora. Mycologia. 1974;66(3):490-498. https://doi.org/10.1080/00275514.1974.12019630

  2. Campos-Macias P, Arenas R. Pigmented Onychomycosis (Fungal Melanonychia). En: Onychomycosis. Springer; 2017. p. 85-101. https://doi.org/10.1007/978-3-319-44853-4_9

  3. Revankar SG. Phaeohyphomycosis: infection due to dark (dematiaceous) molds. En: Diagnosis and treatment of fungal infections. Springer; 2015. p. 151-157. https://doi.org/10.1007/978-3-319-13090-3_12

  4. Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment. J Cutan Med Surg. 2017;21(6):525- 539. https://doi.org/10.1177/1203475417716362

  5. Hay RJ, Ashbee HR. Fungal infections. Rooks Textb Dermatol Ninth Ed. 2016;1- 110. https://doi.org/10.1002/9781118441213.rtd0033

  6. Chowdhary A, Perfect J, de Hoog GS. Black molds and melanized yeasts pathogenic to humans. Cold Spring Harb Perspect Med. 2015;5(8):a019570. https://doi.org/10.1101/cshperspect.a019570

  7. Hussain N, Revankar SG. Black mold infections: what we know and what we need to know. Curr Clin Microbiol Rep. 2017;4(2):106-111. https://doi.org/10.1007/s40588-017-0062-x

  8. Hay RJ. Dermatophytosis (ringworm) and other superficial mycoses. Mand Douglas Bennett's Princ Pract Infect Dis Eighth Ed Phila PA Elsevier. 2015;2985-994. Disponible en: https://1a2ee5a1-a-62cb3a1a-ssites. googlegroups.com/site/mandell2020c/home/266-DermatophytosisRingworm.pdf?attachauth=AN oY7cpwE2OqjN4fOJr4kZb8aj_QxZhAXIPxCRJpMn0s2UiGWJ7ZgFhPB_3-B3bLfk9FhirJuetwV7x4zhVUt1hZduUV-_ Zybzk98AhlbVarY8uOxocnHIGtJgNOVn06UiMDnHQsDEeu9EoLlx8jWkUKEYdP rWF38 PhmT5DRpX6vqOmxHjrZrFrbGiH9hGK5XXuWDd8hmdFHmRQYl-e-LbhJJDnBtI_Tf6trx-uMb5M-ePdKG cK20K8clUh8IM5H0JiZkMNT67s&attredirects=0

  9. Shokoohi GR, Ansari S, Abolghazi A, Gramishoar M, Nouripour-Sisakht S, Mirhendi H, et al. The First Case of Fingernail Onychomycosis Due to Neoscytalidium novaehollandiae, Molecular Identification and Antifungal Susceptibility. J Mycol Médicale. 2019;100920. https://doi.org/10.1016/j.mycmed.2019.100920

  10. Martínez-Herrera EO, Arroyo-Camarena S, Tejada-García DL, Porras-López CF, Arenas R. Onychomycosis due to opportunistic molds. An Bras Dermatol. 2015;90(3):334- 337. https://doi.org/10.1590/abd1806-4841.20153521

  11. Papini M, Piraccini BM, Difonzo E, Brunoro A. Epidemiology of onychomycosis in Italy: prevalence data and risk factor identification. Mycoses. 2015;58(11):659-664. https://doi.org/10.1111/myc.12396

  12. Elewski BE, Tosti A. Risk factors and comorbidities for onychomycosis: implications for treatment with topical therapy. J Clin Aesthetic Dermatol. 2015;8(11):38. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689496/pdf/jcad_8_11_38.pdf

  13. Cozzani E, Agnoletti AF, Speziari S, Schiavetti I, Zotti M, Persi A, et al. Epidemiological study of onychomycosis in older adults with onychodystrophy. Geriatr Gerontol Int. 2016;16(4):486- 491. https://doi.org/10.1111/ggi.12496

  14. Brandt ME, Warnock DW. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother. 2003;15(sup2):36-47. https://doi.org/10.1179/joc.2003.15.Supplement- 2.36

  15. Romano C, Gianni C, Difonzo EM. Retrospective study of onychomycosis in Italy: 1985-2000. Mycoses. 2005;48(1):42-44. https://doi.org/10.1111/j.1439-0507.2004.01066.x

  16. Smith DF, Casadevall A. The Role of Melanin in Fungal Pathogenesis for Animal Hosts. Fungal Physiol Immunopathogenesis. 2019;1-30. https://doi.org/10.1007/82_2019_173

  17. Gómez LV, Cardona-Castro N. Feohifomicosis, una infección fúngica oportunista emergente. CES Med. 2016;30(1):66-77. https://doi.org/10.21615/cesmedicina.30.1.7

  18. Gupta AK, MacLeod MA, Tosti A. Onychomycosis: Clinical Aspects. En: Scher and Daniel's Nails. Springer; 2018. p. 153-159. https://doi.org/10.1007/978-3-319-65649-6_9

  19. Lipner SR, Scher RK. Onychomycosis: Clinical overview and diagnosis. J Am Acad Dermatol. 2019;80(4):835-851. https://doi.org/10.1016/j.jaad.2018.03.062

  20. Torres-Guerrero E, Arenas R. Candida Onychomycosis. En: Onychomycosis. Springer; 2017. p. 73- 83. https://doi.org/10.1007/978-3-319-44853-4_8

  21. Lipner SR, Scher RK. Onychomycosis: Clinical overview and diagnosis. J Am Acad Dermatol. 2019;80(4):835-851. https://doi.org/10.1016/j.jaad.2018.03.062

  22. Eenglish MP. NAILS AND FUNGI. British Journal of Dermatology. 1976 06;94(6):697- 701. https://doi.org/10.1111/j.1365-2133.1976.tb05171.x

  23. Saldaña M, Férez-Blando K, Domínguez-Cherit J, Fierro-Arias L, Bonifaz A. Fungal Leukonychia and Melanonychia: a Review. Curr Fungal Infect Rep. 2017;11(3):110-116. https://doi.org/10.1007/s12281- 017-0289-2

  24. Tseng Y-T, Liang C-W, Liau J-Y, Chang K, Tseng Y-H, Chen J-S, et al. Longitudinal melanonychia: differences in etiology are associated with patient age at diagnosis. Dermatology. 2017;233(6):446- 455. https://doi.org/10.1159/000486701

  25. Koga H. Dermoscopic evaluation of melanonychia. J Dermatol. 2017;44(5):515- 517. https://doi.org/10.1111/1346-8138.13863

  26. Haneke E. Important malignant and new nail tumors. JDDG J Dtsch Dermatol Ges. 2017;15(4):367- 386. https://doi.org/10.1111/ddg.13223

  27. Cob-Delgado M, Valverde-Brenes J. Dermatomicosis por Neoscytalidium dimidiatum Reporte de un caso Dermatomycosis by Neoscytalidium dimidiatum. Rev. Colegio de Microb Quim Clin de Costa Rica. 2018: 24 (3). Disponible en: http://revista.microbiologos.cr/wp-content/uploads/2018/12/Art%C3%ADculo-6.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Revista Médica Sinergia. 2020;5